Insmed Incorporated
Insmed Incorporated (INSM) Stock Overview
Explore Insmed Incorporated’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
30.1B
P/E Ratio
-23.28
EPS (TTM)
$-6.42
ROE
-1.68%
INSM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Insmed Incorporated (INSM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 36.20, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $227.84.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -23.28 and a market capitalization of 30.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.